Based on the price of the KBC Group share on 31 December 2025 (EUR 111.25), the net asset value of one KBC Ancora share ...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene ...

Interim financial results, Q1 2025/26 Coloplast delivered Q1 organic growth of 6% and EBIT growth1 in constant currencies of 3%. Reported revenue in DKK grew 0%, reflecting 4%-points negative impact ...

Bilibili Inc., a leading video community for young generations in China, released its unaudited interim financial results for the first quarters of 2024 and 2025. The report includes consolidated ...

Operating income decreased to €0.04 million from €1.7 million over the period. In the first half of 2025, income mainly reflects the Research Tax Credit (CIR), partly offset by the accounting impact ...

Meudon (France), July 25th 2025 – The Vallourec Interim financial report ended 30 June 2025 has been made available to the public and filed with the French securities regulator (Autorité des Marchés ...

Strong net sales growth, well on track to achieve full year outlook (1) In Q3 2025, Nokia changed how it presents gains and losses from venture fund investments. The comparative financial information ...

This press release contains certain statements, estimates and forecasts with respect to future performance and events. These statements, estimates and forecasts are "forward-looking statements". In ...

IperionX is a leading American titanium metal and critical materials company – using patented metal technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, ...

Pursuant to the Article 193-2, Paragraph 1 of the Financial Instruments and Exchange Act of Japan, we have reviewed the condensed interim consolidated financial statements included in the "Condensed ...

During the period from inception of the Company to 26 March 2019, the investment objective of the Company and the Master Fund SAC was to give their Shareholders the opportunity to participate in the ...

Currently, all reporting issuers in Canada must file interim financial reports and accompanying management’s discussion and analysis (“MD&A”) on a quarterly basis. The SAR Pilot was developed in ...